🇺🇸 FDA
Pipeline program

Immune Globulin Infusion (Human), 10% Solution

RG1123550

Phase 2 mab active

Quick answer

Immune Globulin Infusion (Human), 10% Solution for Hematologic Malignancies is a Phase 2 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hematologic Malignancies
Phase
Phase 2
Modality
mab
Status
active

Clinical trials